Rapid Glucocorticoid Receptor-Mediated Inhibition of Hypothalamic–Pituitary–Adrenal Ultradian Activity in Healthy Males
- Georgina M. Russell1,
- David E. Henley1,2,
- Jack Leendertz1,
- Jennie A. Douthwaite1,
- Susan A. Wood1,
- Adam Stevens3,
- Wolfram W. Woltersdorf4,
- Bernard W. M. M. Peeters5,
- Ge S. F. Ruigt5,
- Anne White3,
- Johannes D. Veldhuis6, and
- Stafford L. Lightman1
- 1Henry Wellcome Laboratories for Integrative Neurosciences and Endocrinology, University of Bristol, Bristol BS1 3NY, United Kingdom,
- 2Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley 6009, Western Australia, Australia,
- 3Endocrine Sciences Research Group, Manchester Academic Health Sciences Center, University of Manchester, Manchester M13 9PT, United Kingdom,
- 4University Hospitals Bristol National Health Science Foundation Trust, Department of Laboratory Medicine, Bristol BS2 8HW, United Kingdom,
- 5Schering-Plough, 5340BH Oss, The Netherlands, and
- 6Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905
- Correspondence should be addressed to Georgina M. Russell, Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Dorothy Hodgkin Building, University of Bristol, Whitson Street, Bristol BS1 3NY, UK. Georgina.Russell{at}bristol.ac.uk
Abstract
A complex dynamic ultradian rhythm underlies the hypothalamic–pituitary–adrenal (HPA) circadian rhythm. We have investigated in normal human male subjects the importance, site of action, and receptor-mediated processes involved in rapid basal corticosteroid feedback and its interaction with corticotrophin releasing hormone (CRH) drive. Pro-opiomelanocortin (POMC), ACTH, and cortisol were measured every 10 min from healthy males during the awakening period or late afternoon using an automated blood sampling system. Mathematical modeling into discrete pulses of activity revealed that intravenous infusion of the synthetic mixed glucocorticoid/mineralocorticoid agonist prednisolone produced rapid inhibition of ACTH and cortisol pulsatility within 30 min in the morning and afternoon. Any pulse that had commenced at the time of injection was unaffected, and subsequent pulsatility was inhibited. Prednisolone also inhibited ACTH and cortisol secretion in response to exogenous CRH stimulation, inferring rapid feedback inhibition at the anterior pituitary. Circulating POMC peptide concentrations were unaffected, suggesting that the rapid corticosteroid inhibitory effect specifically targeted ACTH secretion from pituitary corticotrophs. Prednisolone fast feedback was only reduced by glucocorticoid receptor antagonist pretreatment and not by mineralocorticoid receptor antagonism, suggesting a glucocorticoid receptor-mediated pathway. The intravenous prednisolone suppression test provides a powerful new tool to investigate HPA abnormalities underlying metabolic and psychiatric disease states.
- Copyright © 2010 the authors 0270-6474/10/306106-10$15.00/0





